Showing results (431-440 of 444) with videos related to

Sort By:
Pageof 45
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Biorxiv : the Preprint Server for Biology|November 9, 2021
Camel nanobodies broadly neutralize SARS-CoV-2 variantsJessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variantsJessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PETStanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2023
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor EfficacyRosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Engineering CAR T Cells for Hepatocellular Carcinoma Recurrence after Liver TransplantationLorenz Kocheise, Gabriel Bacil, Pavan Bhimalli, et al.
Cell Reports. Medicine|July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in miceNan Li, Madeline B Torres, Madeline R Spetz, et al.
Leukemia|July 22, 2018
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemiaRobert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastomaIra Phadke, Divya Nambiar, George Diehl, et al.
Pageof 45